Douillet DC, et al. (2019) Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR. J Biol Chem 294(3):805-815 PMID:30478173
Albrecht D, et al. (2018) Multiple chemo-genetic interactions between a toxic metabolite and the ubiquitin pathway in yeast. Curr Genet 64(6):1275-1286 PMID:29721631
Albrecht D, et al. (2016) Chemo-Genetic Interactions Between Histone Modification and the Antiproliferation Drug AICAR Are Conserved in Yeast and Humans. Genetics 204(4):1447-1460 PMID:27707786
Ceschin J, et al. (2015) Disruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Monophosphate (AICAR). J Biol Chem 290(39):23947-59 PMID:26283791
Ceschin J, et al. (2014) Identification of yeast and human 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) transporters. J Biol Chem 289(24):16844-54 PMID:24778186
Laporte D, et al. (2013) An array of nuclear microtubules reorganizes the budding yeast nucleus during quiescence. J Cell Biol 203(4):585-94 PMID:24247429